The global MicroRNA market size in 2023 is 1503.4 million US dollars, and it is expected to be 5386.8 million US dollars by 2030, with a compound annual growth rate of 20.0% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the MicroRNA market include Merck KGaA, QIAGEN, Thermo Fisher Scientific Inc., Synlogic, and GeneCopoeia, Inc. The share of the top 3 players in the MicroRNA market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of MicroRNA market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Instruments accounted for XX% of MicroRNA market in 2023. Consumables share of XX%.
Cancer accounted for XX% of the MicroRNA market in 2023. Infectious Diseases accounts for XX%.
This MicroRNA market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.
MicroRNA market country level analysis
The countries covered in the MicroRNA market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.
Competitive Landscape and MicroRNA Market Share Analysis
MicroRNA market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the MicroRNA market.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the MicroRNA industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of MicroRNA market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapters 4-6: Segmented the global MicroRNA market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa MicroRNA market type, application, country and player market segmentation data, and include SWOT Analysis.
Chapter 12: Analyzes the MicroRNA business cost, including industrial chain and the proportion of business cost structure.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa
Player list
Merck KGaA
QIAGEN
Thermo Fisher Scientific Inc.
Synlogic
GeneCopoeia, Inc
Horizon Discovery Ltd.
New England Biolabs
Quantabio
NanoString
BioGenex
SeqMatic LLC
Miltenyi Biotec
Agilent Technologies, Inc
Promega Corporation
Abcam plc
KANEKA CORPORATION
Types list
Instruments
Consumables
Application list
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others
Table of Content
1 Market Overview
1.1 MicroRNA Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global MicroRNA Market Size & Forecast
1.4.1 Global MicroRNA Revenue (2019 VS 2023 VS 2030)
1.4.2 Global MicroRNA Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 MicroRNA Market Drivers
1.5.2 MicroRNA Market Restraints
1.5.3 MicroRNA Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Merck KGaA
2.1.1 Business Overview
2.1.2 Merck KGaA SWOT Analysis
2.1.3 Merck KGaA MicroRNA Products and Service Offered
2.1.4 Merck KGaA MicroRNA Revenue and Gross Margin
2.2 QIAGEN
2.2.1 Business Overview
2.2.2 QIAGEN SWOT Analysis
2.2.3 QIAGEN MicroRNA Products and Service Offered
2.2.4 QIAGEN MicroRNA Revenue and Gross Margin
2.3 Thermo Fisher Scientific Inc.
2.3.1 Business Overview
2.3.2 Thermo Fisher Scientific Inc. SWOT Analysis
2.3.3 Thermo Fisher Scientific Inc. MicroRNA Products and Service Offered
2.3.4 Thermo Fisher Scientific Inc. MicroRNA Revenue and Gross Margin
2.4 Synlogic
2.4.1 Business Overview
2.4.2 Synlogic SWOT Analysis
2.4.3 Synlogic MicroRNA Products and Service Offered
2.4.4 Synlogic MicroRNA Revenue and Gross Margin
2.5 GeneCopoeia, Inc
2.5.1 Business Overview
2.5.2 GeneCopoeia, Inc SWOT Analysis
2.5.3 GeneCopoeia, Inc MicroRNA Products and Service Offered
2.5.4 GeneCopoeia, Inc MicroRNA Revenue and Gross Margin
2.6 Horizon Discovery Ltd.
2.6.1 Business Overview
2.6.2 Horizon Discovery Ltd. SWOT Analysis
2.6.3 Horizon Discovery Ltd. MicroRNA Products and Service Offered
2.6.4 Horizon Discovery Ltd. MicroRNA Revenue and Gross Margin
2.7 New England Biolabs
2.7.1 Business Overview
2.7.2 New England Biolabs SWOT Analysis
2.7.3 New England Biolabs MicroRNA Products and Service Offered
2.7.4 New England Biolabs MicroRNA Revenue and Gross Margin
2.8 Quantabio
2.8.1 Business Overview
2.8.2 Quantabio SWOT Analysis
2.8.3 Quantabio MicroRNA Products and Service Offered
2.8.4 Quantabio MicroRNA Revenue and Gross Margin
2.9 NanoString
2.9.1 Business Overview
2.9.2 NanoString SWOT Analysis
2.9.3 NanoString MicroRNA Products and Service Offered
2.9.4 NanoString MicroRNA Revenue and Gross Margin
2.10 BioGenex
2.10.1 Business Overview
2.10.2 BioGenex SWOT Analysis
2.10.3 BioGenex MicroRNA Products and Service Offered
2.10.4 BioGenex MicroRNA Revenue and Gross Margin
2.11 SeqMatic LLC
2.11.1 Business Overview
2.11.2 SeqMatic LLC SWOT Analysis
2.11.3 SeqMatic LLC MicroRNA Products and Service Offered
2.11.4 SeqMatic LLC MicroRNA Revenue and Gross Margin
2.12 Miltenyi Biotec
2.12.1 Business Overview
2.12.2 Miltenyi Biotec SWOT Analysis
2.12.3 Miltenyi Biotec MicroRNA Products and Service Offered
2.12.4 Miltenyi Biotec MicroRNA Revenue and Gross Margin
2.13 Agilent Technologies, Inc
2.13.1 Business Overview
2.13.2 Agilent Technologies, Inc SWOT Analysis
2.13.3 Agilent Technologies, Inc MicroRNA Products and Service Offered
2.13.4 Agilent Technologies, Inc MicroRNA Revenue and Gross Margin
2.14 Promega Corporation
2.14.1 Business Overview
2.14.2 Promega Corporation SWOT Analysis
2.14.3 Promega Corporation MicroRNA Products and Service Offered
2.14.4 Promega Corporation MicroRNA Revenue and Gross Margin
2.15 Abcam plc
2.15.1 Business Overview
2.15.2 Abcam plc SWOT Analysis
2.15.3 Abcam plc MicroRNA Products and Service Offered
2.15.4 Abcam plc MicroRNA Revenue and Gross Margin
2.16 KANEKA CORPORATION
2.16.1 Business Overview
2.16.2 KANEKA CORPORATION SWOT Analysis
2.16.3 KANEKA CORPORATION MicroRNA Products and Service Offered
2.16.4 KANEKA CORPORATION MicroRNA Revenue and Gross Margin
3 Global MicroRNA Market Competition, by Manufacturer
3.1 Global MicroRNA Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 MicroRNA Players Market Share in 2023
3.2.2 Top 6 MicroRNA Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 MicroRNA Players Head Office, Business Provided
3.4 MicroRNA Mergers & Acquisitions
3.5 MicroRNA New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global MicroRNA Revenue in Value by Type (2019-2030)
4.2 Global MicroRNA Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global MicroRNA Revenue by Application (2019-2030)
5.2 Global MicroRNA Revenue Share by Application (2019-2030)
6 Global MicroRNA Market Analysis by Regions
6.1 Global MicroRNA Revenue and Market Share by Regions
6.1.1 Global MicroRNA Revenue by Regions (2019-2030)
6.1.2 Global MicroRNA Revenue Market Share by Regions (2019-2030)
6.2 North America MicroRNA Revenue and Growth (2019-2030)
6.3 Europe MicroRNA Revenue and Growth (2019-2030)
6.4 Asia Pacific MicroRNA Revenue and Growth (2019-2030)
6.5 South America MicroRNA Revenue and Growth (2019-2030)
6.6 Middle East and Africa MicroRNA Revenue and Growth (2019-2030)
7 North America MicroRNA by Country, by Type, and by Application
7.1 North America MicroRNA Revenue by Type (2019-2030)
7.2 North America MicroRNA Revenue by Application (2019-2030)
7.3 North America MicroRNA Revenue and Market Share by Countries
7.3.1 North America MicroRNA Revenue in Value by Country (2019-2030)
7.3.2 United States MicroRNA Revenue and Growth (2019-2030)
7.3.3 Canada MicroRNA Revenue and Growth (2019-2030)
7.3.4 Mexico MicroRNA Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe MicroRNA by Country, by Type, and by Application
8.1 Europe MicroRNA Revenue by Type (2019-2030)
8.2 Europe MicroRNA Revenue by Application (2019-2030)
8.3 Europe MicroRNA Revenue and Market Share by Countries
8.3.1 Europe MicroRNA Revenue in Value by Country (2019-2030)
8.3.2 Germany MicroRNA Revenue and Growth (2019-2030)
8.3.3 France MicroRNA Revenue and Growth (2019-2030)
8.3.4 United Kingdom MicroRNA Revenue and Growth (2019-2030)
8.3.5 Russia MicroRNA Revenue and Growth (2019-2030)
8.3.6 Italy MicroRNA Revenue and Growth (2019-2030)
8.3.7 Nordic MicroRNA Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific MicroRNA by Country, by Type, and by Application
9.1 Asia Pacific MicroRNA Revenue by Type (2019-2030)
9.2 Asia Pacific MicroRNA Revenue by Application (2019-2030)
9.3 Asia Pacific MicroRNA Revenue and Market Share by Countries
9.3.1 Asia Pacific MicroRNA Revenue in Value by Country (2019-2030)
9.3.2 China MicroRNA Revenue and Growth (2019-2030)
9.3.3 Japan MicroRNA Revenue and Growth (2019-2030)
9.3.4 Korea MicroRNA Revenue and Growth (2019-2030)
9.3.5 India MicroRNA Revenue and Growth (2019-2030)
9.3.6 Southeast Asia MicroRNA Revenue and Growth (2019-2030)
9.3.7 Australia MicroRNA Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America MicroRNA by Country, by Type, and by Application
10.1 South America MicroRNA Revenue by Type (2019-2030)
10.2 South America MicroRNA Revenue by Application (2019-2030)
10.3 South America MicroRNA Revenue and Market Share by Countries
10.3.1 South America MicroRNA Revenue in Value by Country (2019-2030)
10.3.2 Brazil MicroRNA Revenue and Growth (2019-2030)
10.3.3 Argentina MicroRNA Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa MicroRNA by Country, by Type, and by Application
11.1 Middle East & Africa MicroRNA Revenue by Type (2019-2030)
11.2 Middle East & Africa MicroRNA Revenue by Application (2019-2030)
11.3 Middle East & Africa MicroRNA Revenue and Market Share by Countries
11.3.1 Middle East & Africa MicroRNA Revenue in Value by Country (2019-2030)
11.3.2 Turkey MicroRNA Revenue and Growth (2019-2030)
11.3.3 Egypt MicroRNA Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia MicroRNA Revenue and Growth (2019-2030)
11.3.5 UAE MicroRNA Revenue and Growth (2019-2030)
11.3.6 South Africa MicroRNA Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 MicroRNA Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 MicroRNA Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer
